Veracyte | VCYT - Ordinary Share Capital


Veracyte reported $78.67M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Agenus USD 266K 30K Mar/2025
Agilent USD 283.05M 540K Sep/2025
Anika Therapeutics USD 143K 1000 Mar/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Bruker USD 151.94M 225K Dec/2025
Exact Sciences USD 189.45M 232K Sep/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
Illumina USD 152.8M 900K Dec/2025
Intrexon USD 0 0 Jun/2024
Karyopharm Therapeutics USD 13K 0 Sep/2024
Laboratory Of America USD 82.2M 700K Dec/2025
Ligand Pharmaceuticals USD 20K 0 Mar/2025
Myriad Genetics USD 93.1M 0 Sep/2025
Rigel Pharmaceuticals USD 17K 158K Jun/2024
Roche Holding CHF 795.62M 699.54K Dec/2025
Siemens EUR 780.74M 6.33M Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Veracyte USD 78.67M 73K Sep/2025
Waters USD 98.08M 38.55M Dec/2025